Skip to main content
Kane Biotech Inc. logo

Kane Biotech Inc. — Investor Relations & Filings

Ticker · KNE ISIN · CA4838092084 TSXV Manufacturing
Open in API
Filings indexed 218 across all filing types
Latest filing 2026-04-25 Management Reports
Country CA Canada
Listing TSXV KNE

About Kane Biotech Inc.

https://kanebiotech.com/

Kane Biotech Inc. is a biotechnology company engaged in the research, development, and commercialization of proprietary technologies designed to prevent and remove microbial biofilms, which are a major contributor to chronic infections and impaired healing. The company holds extensive intellectual property related to biofilm formation and dispersal mechanisms, utilizing proprietary technologies such as DispersinB® and coactiv+®. Its primary commercial focus is advanced wound care, where products like the revyve® Antimicrobial Wound Gel and Spray are designed to disrupt biofilms and promote healing. The product pipeline also includes surgical and dermatological applications for both human and animal health.

Recent filings

Filing Released Lang Actions
Annual MD&A - English.pdf
Management Reports Classification · 1% confidence The document is the Management Discussion and Analysis (MD&A) covering years ended December 31, 2025 and 2024, including forward-looking statements, business overview, strategic initiatives, corporate events, and detailed commentary on financial performance, risks, and outlook. This aligns exactly with the definition of a Management Report (Code: MDA) which provides management’s detailed explanation of financial results, business trends, and outlook.
2026-04-25 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a statutory certification (“Venture Issuer Basic Certificate”) under Canadian securities rules (NI 52-109) by the CEO confirming review of the annual financial statements, MD&A and AIF for the year ended December 31, 2025. This is not the Annual Report itself (10-K or IR), nor is it an earnings release, MD&A narrative, or any specific category like director changes or financing updates. It is a mandatory regulatory filing that does not fit another defined category, so it falls into the general “Regulatory Filings” classification.
2026-04-25 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a statutory certification (Venture Issuer Basic Certificate) under National Instrument 52-109, signed by the CFO, certifying the annual filings (AIF, financial statements, MD&A). It is not the annual report itself nor a notice announcing publication. This type of certificate is a miscellaneous regulatory filing under securities legislation. Therefore, it falls under the fallback category Regulatory Filings (RNS).
2026-04-25 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 1% confidence The document is a Form 13-501F1 “Participation Fee Management Certification” filed with the Alberta Securities Commission. It is a routine regulatory filing to calculate and certify the issuer’s participation fee based on market values. It does not represent an earnings release, annual report, management announcement, or any other specific category in the taxonomy. Therefore it falls under the general “Regulatory Filings” category (RNS).
2026-04-25 English
Audited annual financial statements – English.pdf
Regulatory Filings
2026-04-25 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a statutory Venture Issuer Basic Certificate by the CFO certifying the annual filings (AIF, annual financial statements, MD&A) under NI 52-109. It is not the annual report itself, nor an earnings release, board change, or proxy. It is a formal regulatory submission with no specific category, so it falls into the fallback “Regulatory Filings” category (RNS).
2026-04-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.